If dose flexibility is allowed to manage early gastrointestinal adverse events, why not to apply the same approach for less common but still possible late adverse events associated with either excessive or too fast weight loss
Autoimmune thyroid disease frequently coexists with metabolic syndrome, a cluster of conditions including obesity, insulin resistance, dyslipidemia, and fatty liver disease
Saremi, H.J.L
An inherent limitation of our study, which relies on bulk mRNA expression data from TCGA to infer protein expression, function, and clinical implications
Possible oral-health risks with GLP-1 use include reduced saliva from eating less, vomiting or acid reflux that exposes teeth to stomach acid, and nutritional gaps that can affect gums
Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver